Drawing for CHEMOPALRX

USPTO serial 88109708

CHEMOPALRX

Reviewed by CopyMark Law Group

Reg. 6014479Status 701Renewal
Filing date
Status date
Registration date
Mar 17, 2020
Examiner
SWAIN, MICHELE LYNN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with CHEMOPALRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of a mobile application for allowing physicians to safely and efficiently prescribe chemotherapy on the goACTIVESep 5, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 1, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jul 1, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jun 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2025ES8RTEAS SECTION 8 RECEIVED
Mar 17, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 11, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2020ALIEASSIGNED TO LIE
Jan 15, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE
Nov 15, 2019EX1GSOU EXTENSION 1 GRANTED
Nov 14, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 4, 2019IUAFUSE AMENDMENT FILED
Nov 4, 2019NREVNOTICE OF REVIVAL - E-MAILED
Nov 4, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 4, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Nov 4, 2019PETGPETITION TO REVIVE-GRANTED
Nov 4, 2019PROATEAS PETITION TO REVIVE RECEIVED
Oct 28, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 28, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 26, 2019EXT1SOU EXTENSION 1 FILED
Mar 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2018DOCKASSIGNED TO EXAMINER
Sep 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance